PT-141 vs Semax

PT-141 and Semax are both widely studied research peptides, but they differ significantly in mechanism, application, and research focus.

PT-141

PT-141 is a melanocortin-focused peptide that has been extensively studied in laboratory settings. Its specific mechanism makes it particularly suited for certain research applications.

Semax

Semax operates through a different pathway, focusing on nootropic-related biological processes. Researchers choose between these compounds based on their specific experimental objectives.

Key Differences

The primary differences lie in receptor selectivity, half-life, and downstream effects. Some protocols may benefit from using both compounds to investigate complementary pathways.

Both Available at Proxiva

Proxiva Peptides offers both PT-141 and Semax at 99.9% verified purity with COA included.

Browse our full research peptide catalog at Proxiva Peptides.

All products are for laboratory and research use only. Not for human consumption.